Stryker reported goodwill and other impairments of $818 million related to the spine business in the fourth quarter.

UroMems, a global medical technology company developing the first smart automated implant to treat stress urinary incontinence (SUI), announced today that Dan Rose has been appointed as the new ...

Q4 2024 Earnings Call Transcript January 28, 2025 Stryker Corporation beats earnings expectations. Reported EPS is $4.01, ...

I would now like to turn over the call to Mr. Kevin Lobo, Chair and Chief Executive Officer. You may proceed ... who will expand on our strategic rationale for the pending Inari acquisition. Jason ...

Inari Medical Inc., one of Orange County’s fastest-growing medical ... saving solutions to patients who suffer from peripheral vascular diseases,” Stryker CEO Kevin Lobo said in a statement. “These ...

Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2024: Fourth Quarter Results Full Year Results “We delivered another year of double-digit organic sales growth ...

New York: Medical-device maker Stryker on Monday agreed to acquire Inari Medical ... from peripheral vascular diseases," said Stryker CEO Kevin Lobo. "These innovations elevate the standard ...

Stryker’s Chairman and CEO, Kevin Lobo, emphasized that this ... For additional information, read Inari Medical’s 8K filing here. Inari Medical, Inc builds minimally invasive, novel, and ...

U.S. stock futures are little changed in the wake of tech sector gains; Nvidia (NVDA) stock is adding to all-time highs in premarket trading on remarks from CEO Jensen Huang; Uber Technologies ...

NEW YORK: Medical-device maker Stryker has agreed to acquire Inari Medical ... peripheral vascular diseases,” said Stryker chief executive officer Kevin Lobo. “These innovations elevate ...